Related Experiment Video
Updated: Oct 10, 2026

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data
Published on: February 7, 2025
MDM2 mediated nuclear exclusion of p53 attenuates etoposide-induced apoptosis in neuroblastoma cells
A M Rodriguez-Lopez1, D Xenaki, T O Eden
1Department of Biochemistry, University of Oxford, South Parks Road, Oxford, U.K.
Abstract:
The p53 gene in neuroblastoma tumors (NB) is rarely mutated but the protein accumulates in the cytoplasm. Because p53 can mediate the cytotoxic effects of chemotherapeutic agents, it is important to determine whether accumulation of p53 in the cytoplasm impairs p53 function. Data presented here indicate that hyperactive nuclear export of p53 suppresses etoposide-induced apoptosis but does not prevent growth arrest. We compared p53 function in a pair of NB subclones. Our data show etoposide induces complete trans-location of p53 to the nucleus and activation of apoptosis in the neuroblastic NB cell line SH-SY5Y (N-type), which expresses low levels of MDM2. However, in Schwann cell-like SH-EP1 cells (S-type), which have up to 10-fold higher levels of MDM2, p53 accumulates in the cytoplasm and the cells are extremely resistant to etoposide-induced apoptosis. Notably, when MDM2 expression is inhibited in S-type cells, with a phosphorothioated antisense oligonucleotide (AS5), then p53 accumulates in the nucleus and the SH-EP1 cells undergo apoptosis. Surprisingly, induction of p21 and G1-arrest are not attenuated in S-type cells, despite the predominantly cytoplasmic location of p53. Whereas, G1-arrest is attenuated in the SH-SY5Y cells, which have high levels of nuclear p53. Taken together, these findings suggest attenuation of G1-arrest is related to the differentiation status of neuroblastomas and occurs downstream of p53 nuclear accumulation. These results demonstrate for the first time that hyperactive nuclear export of p53 attenuates chemotherapy-induced apoptosis in NB cells, and our findings suggest that inhibitors of MDM2 may enhance the therapeutic efficacy of etoposide by promoting apoptosis rather than trans-differentiation.
Insights
Cytoplasmic accumulation of p53 protein in neuroblastoma suppresses chemotherapy-induced apoptosis but not growth arrest. Inhibiting MDM2 enhances etoposide efficacy by promoting apoptosis over trans-differentiation in neuroblastoma cells.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The p53 tumor suppressor protein is crucial for mediating chemotherapy's cytotoxic effects.
- In neuroblastoma, p53 is rarely mutated but often accumulates in the cytoplasm, questioning its functional status.
- Understanding p53's localization is key to deciphering its role in neuroblastoma treatment resistance.
Purpose of the Study:
- To investigate whether cytoplasmic p53 accumulation impairs its function in neuroblastoma.
- To determine the impact of p53 nuclear export on etoposide-induced apoptosis and growth arrest.
- To explore the role of MDM2 in regulating p53 localization and chemosensitivity in neuroblastoma.
Main Methods:
- Comparison of p53 function in two neuroblastoma subclones (SH-SY5Y and SH-EP1) with differing MDM2 levels.
- Treatment with etoposide to assess apoptosis and growth arrest.
- Inhibition of MDM2 expression using a phosphorothioated antisense oligonucleotide (AS5).
- Analysis of p53 translocation, apoptosis, p21 induction, and G1-arrest.
Main Results:
- Hyperactive nuclear export of p53 suppressed etoposide-induced apoptosis in SH-EP1 cells (high MDM2) but not growth arrest.
- SH-SY5Y cells (low MDM2) showed nuclear p53 translocation and apoptosis upon etoposide treatment.
- Inhibiting MDM2 in SH-EP1 cells restored nuclear p53 accumulation and induced apoptosis.
- G1-arrest was not attenuated in S-type cells despite cytoplasmic p53, but was attenuated in N-type cells with high nuclear p53.
Conclusions:
- Hyperactive nuclear export of p53 attenuates chemotherapy-induced apoptosis in neuroblastoma cells.
- G1-arrest attenuation is linked to neuroblastoma differentiation status and occurs downstream of p53 nuclear accumulation.
- MDM2 inhibitors may enhance etoposide efficacy by promoting apoptosis rather than trans-differentiation in neuroblastoma.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Mitogens and the Cell Cycle

